Cited by 122Blood Pressure and Hypertension StudiesAcute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage Research

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Chronic Management of Blood Pressure After Stroke

Open access

Pedelty, Laura, Gorelick, Philip B.·2004·Hypertension

DOI 10.1161/01.hyp.0000129170.50448.5f

Open this paper in CoChat — free account Open PDF

Abstract

A 70-year-old, right-handed African American woman with diabetes mellitus, treated with an oral hypoglycemic, and untreated mild hypertension developed right-sided face, arm, and leg weakness while at home preparing breakfast.She was able to reach the telephone and dial 911.An ambulance was summoned, and the Emergency Medical Service team, on arrival, noted a right facial droop, dysarthria, and right-sided weakness.She was transported to a local hospital, arriving within an hour of the onset of the event.The hospital stroke team was consulted and initiated an evaluation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000129170.50448.5f

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
MACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
(2001) · The Lancet · doi:10.1016/s0140-6736(01)06178-5 · Cited by 3,178
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension: Final Results of the Systolic Hypertension in the Elderly Program (SHEP)
(1991) · JAMA · doi:10.1001/jama.1991.03460240051027 · Cited by 2,953
The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
(2004) · PsycEXTRA Dataset · doi:10.1037/e442802008-001 · Cited by 2,883
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14739-3 · Cited by 2,402
Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000
Hajjar, I. M. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,399
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
Hansson, L., Lindholm, L. H., NISKANEN, L. K., Lanke, J., Hedner, T., Niklason, A., LUOMANMÄKI, K., Dahlöf, B., Fairé, U. D., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 1,991
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Dahlöf, B., Hansson, L., Lindholm, L. H., Scherstén, B., Ekbom, T., & Wester, P.-O. (1991) · The Lancet · doi:10.1016/0140-6736(91)92589-t · Cited by 1,877
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials
(2000) · The Lancet · doi:10.1016/s0140-6736(00)03307-9 · Cited by 1,790
Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States
Wolf-Maier, K. (2003) · JAMA · doi:10.1001/jama.289.18.2363 · Cited by 1,728
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
Wing, L. M. H., Reid, C. M., Ryan, P., Beilin, L. J., Brown, M. A., Jennings, G. L. R., Johnston, C. I., McNeil, J. J., Macdonald, G. J., Marley, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021716 · Cited by 1,130
Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents
Psaty, B. M., Lumley, T., Furberg, C. D., Lovasi, G. S., Pahor, M., Alderman, M. H., & Weiss, N. S. (2003) · JAMA · doi:10.1001/jama.289.19.2534 · Cited by 1,096
Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients With Cerebrovascular Disease
(2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1069 · Cited by 988
Cardiovascular protection and blood pressure reduction: a meta-analysis
Staessen, J. A., Wang, J., & Thijs, L. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06411-x · Cited by 939
Primary Prevention of Ischemic Stroke
Goldstein, L. B., Adams, R. J., Becker, K. J., Furberg, C. D., Gorelick, P. B., Hádemenos, G. J., Hill, M., Howard, G., Howard, V. J., Jacobs, B. S., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 902
Self-citation
The Prevention of Dementia With Antihypertensive Treatment<subtitle>New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study</subtitle>
Forette, F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2046 · Cited by 898
Income inequality and population health
Mackenbach, J. P. (2002) · BMJ · doi:10.1136/bmj.324.7328.1 · Cited by 850
The National Cholesterol Education Program
Cleeman, J. I. (1989) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30638-3 · Cited by 711
Prevention of a First Stroke
Gorelick, P. B., Sacco, R. L., Smith, D. B., Alberts, M. J., MustoneAlexander, L., Rader, D. J., Ross, J. L., Raps, E. C., Ozer, M. N., Brass, L. M., et al. (1999) · JAMA · doi:10.1001/jama.281.12.1112 · Cited by 493
Self-citation
Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures
Svensson, P., Fairé, U. D., Sleight, P., Yusuf, S., & Östergren, J. (2001) · Hypertension · doi:10.1161/hy1101.099502 · Cited by 490
Alzheimer Disease and Associated Disorders
Post, S. G., & Whitehouse, P. J. (1992) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199205000-00001 · Cited by 461
Dementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-1984)
Kokmen, E., Whisnant, J. P., O'Fallon, W. M., Chu, C.-P., & Beard, C. M. (1996) · Neurology · doi:10.1212/wnl.46.1.154 · Cited by 434
Management of High Blood Pressure in African Americans Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
Douglas, J. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.525 · Cited by 431
Use of ramipril in preventing stroke: double blind randomised trial
Bosch, J., Yusuf, S., Pogue, J., Sleight, P., Lonn, E., Rangoonwala, B., Davies, R., Ostergren, J., & Probstfield, J. (2002) · BMJ · doi:10.1136/bmj.324.7339.699 · Cited by 420
Race-Ethnic Disparities in the Impact of Stroke Risk Factors
Sacco, R. L., Boden-Albala, B. M., Abel, G. A., Lin, I., Elkind, M. S. V., Hauser, W. A., Paik, M. C., & Shea, S. (2001) · Stroke · doi:10.1161/01.str.32.8.1725 · Cited by 378
Primary Prevention of Ischemic Stroke
Goldstein, L. B., Adams, R. J., Becker, K. J., Furberg, C. D., Gorelick, P. B., Hádemenos, G. J., Hill, M., Howard, G., Howard, V. J., Jacobs, B. S., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.163 · Cited by 374
Self-citation
Improved Cognition After Control of Risk Factors for Multi-infarct Dementia
Meyer, J. S. (1986) · JAMA · doi:10.1001/jama.1986.03380160061021 · Cited by 202
[Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials].
Schillaci, G., & Vaudo, G. (2001) · PubMed · Cited by 167
Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.
Gougeon, R., Styhler, K., Morais, J. A., Jones, P. J. H., & Marliss, E. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.1 · Cited by 156
Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population
Qureshi, A. I., Suri, M. F. K., Guterman, L. R., & Hopkins, L. N. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1621 · Cited by 149
Risk factors and their management for stroke prevention: outlook for 1999 and beyond.
Sacco, R. L., Wolf, P. A., & Gorelick, P. B. (1999) · PubMed · Cited by 145
Self-citation
Health outcomes associated with various antihypertensive therapies used as first-line agents
Psaty, B. M., Lumley, T., & Furberg, C. D. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00272-1 · Cited by 101
Risk Factors for Dementia Associated With Multiple Cerebral Infarcts
Gorelick, P. B. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540070034011 · Cited by 93
Self-citation
New horizons for stroke prevention: PROGRESS and HOPE
Gorelick, P. B. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00070-4 · Cited by 80
Self-citation
Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease: A Substudy of the LIFE Randomized Trial
Devereux, R. B., Dahlf, B., Kjeldsen, S. E., Julius, S., Aurup, P., Beevers, G., Edelman, J. M., de Faire, U., Fyhrquist, F., Berg, S. H., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00006 · Cited by 68
Prevention of Vascular Dementia
Gorelick, P. B., Erkinjuntti, T., Albert Hofman, D., Rocca, W. A., Skoog, I. G., & Winblad, B. G. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912003-00019 · Cited by 61
Self-citation
Blood Pressure Management in Patients With Acute Ischemic Stroke
Goldstein, L. B. (2004) · Hypertension · doi:10.1161/01.hyp.0000113297.76013.51 · Cited by 48
Clinician's Manual on Blood Pressure and Stroke Prevention
Chalmers, J. P., MacMahon, S. W., Brass, L. M., Chapman, J., Gorelick, P. B., & Neal, B. C. (2002) · Cited by 14
Self-citation
Blood pressure lowering for the prevention of first stroke
Chapman, J., Neal, B. C., & Chalmers, J. P. (2002) · Cited by 1
Progress with Blood Pressure Lowering in the Secondary Prevention of Stroke
Chalmers, J. P. (2002) · Cited by 1

Research works printed but not linked: 4

American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position statement). Diabetes Care. 1999: S32–S41.
10.1161/circ.103.1.163 · DOI
10.1161/str.32.8.1725 · DOI
10.1161/hyp.38.6.e28 · DOI

Sorted by citations

Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030
Sex differences in primary hypertension
Sandberg, K. L., & Ji, H. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-7 · Cited by 459
Mechanisms of Sympathetic Activation in Obesity-Related Hypertension
Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., & Lambert, E. (2006) · Hypertension · doi:10.1161/01.hyp.0000242642.42177.49 · Cited by 443
Translational medicine: the antihypertensive effect of renal denervation
DiBona, G. F., & Esler, M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00647.2009 · Cited by 432
Epidemiology of Uncontrolled Hypertension in the United States
Wang, T. J., & Vasan, R. S. (2005) · Circulation · doi:10.1161/circulationaha.104.490599 · Cited by 372

See all 122

Authors: Pedelty, L., & Gorelick, P. B.
Affiliations: University of Illinois Chicago (US)
ORCID: Gorelick, Philip B.
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-07
Volume: 44
Issue: 1
Pages: 1-5
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/01.hyp.0000129170.50448.5f
OpenAlex: W2096942434
Cited by: 122
References: 50
Citations by year: 2025: 1 · 2022: 1 · 2021: 2 · 2017: 3 · 2015: 5 · 2014: 5 · 2013: 2 · 2012: 5
FWCI: 14.19
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (R01 NS)
National Institute of Neurological Disorders and Stroke (R01 NS33430, R01NS033430)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords: blood pressure control, stroke, diabetes mellitus, acute stroke, stroke rehabilitation, secondary stroke prevention, African American women
MeSH terms: Aged, Antihypertensive Agents, Blood Pressure, Dementia, Female, Humans, Hypertension, Recurrence, Risk, Stroke, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chronic Management of Blood Pressure After Stroke

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks